Bamipine
Bamipine (trade name Soventol) is a pharmaceutical drug acting as an H1 antihistamine with anticholinergic properties. It is used as an antipruritic ointment.[1] No oral use is known.[2]
 | |
| Clinical data | |
|---|---|
| Trade names | Soventol |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral?, topical |
| ATC code | |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.023.261  |
| Chemical and physical data | |
| Formula | C19H24N2 |
| Molar mass | 280.407 g/mol g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
Adverse effects
Side effects are typical of an old (first-generation) antihistamine: tiredness in adults, agitation in children, mydriasis (dilation of the pupils). These effects are rare when bamipine is applied topically as an ointment. Allergic and hypersensitivity reactions are also rare. Acute eczema can be worsened by bamipine ointment.[3]
Contraindications and interactions
No clinically relevant contraindications or interactions with other drugs are known.[3]
Pharmacology
Pharmacokinetics
When applied topically, the maximal effect is reached after 20 to 60 minutes and lasts up to 48 hours. Bamipine is not absorbed through intact skin in relevant doses.[3]
References
- , M Pairet, MP Pieper, CJM Meade, "Pharmaceutical compositions containing tiotropium salts and antihistamines and their use", published 2001
- International Drug Names: Bamipine.
- Haberfeld, H, ed. (2015). Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag. Soventol-Gel.